Tech Logic

Nature study: RNA-triggered CRISPR-Cas12a2 selectively kills cancer cells in cell and mouse models

A Nature study shows that after a research team programmed RNA-guided CRISPR-Cas12a2 to recognize cancer-specific transcripts, it triggered chromatin cleavage, a DNA damage response, and cancer cell death. Secondary reports add p53 mRNA recognition and therapeutic effects in mouse models of lung and liver cancer. All three sources confirm the core mechanism and its potential for selective tumor killing, but some target-combination and model details are described differently across sources, and if a source does not mention them, they cannot be confirmed.

Jun 11, 2026

Redwire Wins Astrobiome Space Contract, ISS Strawberry Greenhouse Project Draws Attention to Commercial Space Agriculture

Redwire announced it has signed with Luxembourg-based Astrobiome Space to deploy its first commercial space greenhouse system aboard the International Space Station for strawberry cultivation. All three sources confirm this core fact, but they differ on the stock-price move, emphasis, and level of technical detail disclosed, and some details were not mentioned by the sources.

Jun 9, 2026

Pacific Fusion Unveils 80-Nanosecond, 440-Gigawatt Pulsar Module Prototype, Drawing Attention to Funding and Demo Plant Progress

Pacific Fusion announced its latest pulser module prototype on June 2, 2026. All three sources confirmed that the prototype was shown externally and cited the performance description “440 gigawatts, 80 nanoseconds.” However, the sources do not fully agree on whether the company has “begun building its first demonstration fusion power plant,” and the specific impact of the test on funding and the timeline cannot be fully verified from the provided sources.

Jun 6, 2026

NASA Abandons “Core Module” Concept, Sparking Debate Over the Viability of Its Commercial Space Station Transition Strategy

On June 1, NASA effectively said it is dropping the previously proposed “core module” approach and adjusting its strategy for transitioning from the International Space Station (ISS) to commercial space stations. Three sources consistently indicate that NASA’s support model for commercial space stations in low Earth orbit is changing, but their accounts differ or do not fully explain the market assessment, funding arrangements, and impact on companies.

Jun 2, 2026

Deep Fission Makes Another Run at Going Public: Underground Nuclear Reactors, AI Data Centers, and Financial Pressure Converge

Deep Fission has filed a new S-1 as it seeks to raise money through a Nasdaq IPO to advance its underground nuclear reactor project. Three sources align on the IPO intent, delays to the first reactor timeline, and rising financial pressure; however, details on valuation, the exact loss figures, and the specifics of a prior reverse-merger listing attempt are only partially confirmed.

May 30, 2026

ΨDNA-Guided CRISPR-Cas12 RNA Targeting Platform: Joint Confirmation by a Nature Paper and Two Interpretive Outlets

Three sources point to the same Nature paper reported in May 2026: the study introduces a ΨDNA/DNA guide that can reprogram Cas12a/Cas12i1 to target intracellular RNA, enabling RNA detection, knockdown, and multiplex targeting. Confirmed facts include its effective depletion or reduction of endogenous RNA; the main differences lie in the emphasis of the media interpretations. Quantitative effects appear only in News-Medical, while mechanistic details appear only in GEN. The Nature excerpt does not provide those numbers or the extended explanations.

May 21, 2026